US Patent Issued to AGENUS, Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center on Dec. 9 for "Anti-CD137 antibodies and methods of use thereof" (American, Dutch, British, German Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,393, issued on Dec. 9, was assigned to AGENUS INC. (Lexington, Mass.), Ludwig Institute for Cancer Research Ltd. (MAZurich, Switzerland) and Memorial Sloan-Kettering Cancer Center (New York).

"Anti-CD137 antibodies and methods of use thereof" was invented by Yanping Xiao (Brookline, Mass.), Nicholas Stuart Wilson (San Carlos, Calif.), Benjamin Maxime Morin (Somerville, Mass.), Mark Arthur Findeis (Belmont, Mass.), Cornelia Anne Mundt (Lorrach, Germany), Marc van Dijk (Bosch en Duin, Netherlands), Dhan Sidhartha Chand (Woburn, Mass.), David Adam Savitsky (Boxford, Mass.), Dennis John Underwood (Jamaica Plain, Mass.) and Olga Ignatovich (Cambridge, Great Britain).

According to the a...